Sun Pharmaceutical Industries informs about change in directorate

21 May 2021 Evaluate
Sun Pharmaceutical Industries has informed that based on the recommendation of the Nomination and Remuneration Committee, the Board of Directors, by way of circular resolutions passed on May 20, 2021, have approved the appointment of Pawan Goenka (DIN: 00254502), as an Additional Independent Director on the Board of the Company, with effect from May 21, 2021, to hold office upto the ensuing 29th Annual General Meeting of the Company; approved the appointment of Rama Bijapurkar (DIN: 00001835), as an Additional Independent Director on the Board of the Company, with effect from May 21, 2021 to hold office upto the ensuing 29th Annual General Meeting of the Company. The Company hereby confirmed that Pawan Goenka and Rama Bijapurkar are not related to any Director of the Company and are also not related to each other. It also confirmed that they both are not debarred from holding the office of Director by virtue of any order issued by the Securities and Exchange Board of India (SEBI) or any such other authority in accordance with the circular dated June 20, 2018, issued by the Stock Exchanges

The above information is a part of company’s filings submitted to BSE.

Sun Pharma Inds. Share Price

1795.30 -9.65 (-0.53%)
08-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1795.30
Dr. Reddys Lab 1267.15
Cipla 1497.45
Zydus Lifesciences 924.35
Lupin 2071.35
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×